FDA Approval and Intended Use Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are specifically FDA-approved for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition
We move beyond quick fixes to focus on consistent, manageable changes that lead to lifelong wellness, ensuring you have the tools to succeed long after your initial sessions
Mari Kemp (00:46:31): I would say we've expanded out to Spanish just because that, again, you're looking at your demographics and that's what really worked for us and we are able to expand to them
Microdosing is like staying in the shallow end, never fully out of the water but not submerged either
APE1 is a 37 kDa ubiquitous multifunctional protein involved in the regulation of multiple transcription factors, including NF-B, STAT3, AP-1, hypoxia-inducible factor-1 (HIF-1), and tumor protein 53 (p53
This delayed gastric emptying is how the medication suppresses appetite and helps with weight loss, but it can also trigger nausea, bloating, and mild stomach discomfort as your digestive system adjusts